Dr. Long is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 NW Expressway
Suite 300
Oklahoma City, OK 73112Phone+1 405-713-7040
Education & Training
University of Utah HealthFellowship, Thoracic Surgery, 1990 - 1992
University of Missouri-ColumbiaResidency, Surgery, 1983 - 1989- University of Missouri-ColumbiaInternship, Internal Medicine, 1982 - 1983
University of Missouri-Columbia School of MedicineClass of 1982
Certifications & Licensure
OK State Medical License 2008 - 2025
UT State Medical License 1990 - 2014- American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Clinical Trials
- REGISTRY EVALUATION OF VITAL INFORMATION FOR VADs IN AMBULATORY LIFE Start of enrollment: 2015 Jul 01
- MOMENTUM 3 IDE Clinical Study Protocol Start of enrollment: 2014 Sep 02
- The ARIES HeartMate 3 Pump IDE Study Start of enrollment: 2020 Jul 14
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Oncostatin M for characterizing the inflammatory burden and outcome of V-V ECMO in ARDS patients.Hendra Setiadi, Ahmed M El-Banayosy, James W Long, Marc O Maybauer, Mircea R Mihu
Artificial Organs. 2023-12-01 - 1 citationsOutcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice.Susan George, Luke C Cunningham, David P Nelson, Douglas A Horstmanshof, James W Long
American Heart Journal Plus. 2022-12-01 - 14 citationsCenter Variability in Patient Outcomes Following HeartMate 3 Implantation: An Analysis of the MOMENTUM 3 Trial.Manreet K Kanwar, Francis D Pagani, Mandeep R Mehra, Jerry D Estep, Sean P Pinney
Journal of Cardiac Failure. 2022-07-01
Press Mentions
VADovations, Inc. Secures Investment and Development Agreement for a Percutaneous Endovascular Delivery System for Its Next-Generation Cardiac Assist Device for Long-Term UseFebruary 11th, 2020
VADovations, Inc. Licenses Intellectual Property from Mayo Clinic to Develop a Novel Next-Generation Endovascular Cardiac Assist Device for Long-Term UseJanuary 29th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
